Accelerate a diverse portfolio of at least 20 high-quality antibacterial products towards clinical development leveraging $250 million in BARDA funds with matching funds from the Wellcome Trust and the AMR Centre.
[email protected]
Industries:
Medical
Health Diagnostics
Life Science
Pharmaceutical
Biotechnology
Medical Device
Biopharma
Program Types:
Accelerator
Program duration:
Investment Stages:
City/State:
Country:
Contact information:
[email protected]
